Melilax is indicated for the treatment of constipation in children and infants, even in the presence of visceral hypersensitivity (such as in the case of irritable bowel syndrome), anal fissures, and hemorrhoids. The product relieves the bowel and reduces the discomfort, irritation, and inflammation present in cases of constipation. Melilax is also suitable for use during pregnancy and breastfeeding. Melilax combines a balanced evacuating action with a protective and soothing action on the rectal mucosa. The dual action of Melilax is achieved thanks to Promelaxin, an active complex of nectar and honeydew honeys specifically selected and treated based on their content of monosaccharides, polysaccharides, and melanoidins, enriched with the polysaccharide fraction of Aloe and Mallow. Melilax exerts a non-irritating evacuating action and, as such, induces a balanced physiological stimulus to activate defecation. Thanks to its mucus-like properties and viscosity, it protects the rectal mucosa during the passage of stool, mimicking the lubricating action of physiological mucus. These special properties, along with its antioxidant action, give the product the ability to protect and soothe the mucosa, performing an indirect anti-inflammatory action thanks to the product's physical characteristics. Food Supplement Medical Device
Comment